New study tests smart lifestyle program to reverse prediabetes
NCT ID NCT05580978
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a lifestyle guide called GEM (Glycemic Excursion Minimization), combined with a continuous glucose monitor (Freestyle Libre 2) and a Fitbit activity tracker, could help people with prediabetes better manage their blood sugar. Sixty-one adults aged 25-70 with prediabetes (A1C 6.0-6.4) used the tools for 4 months. The goal was to see if this approach could reduce high blood sugar readings and improve overall glucose control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
behavioral intervention (GEM lifestyle guide, continuous glucose monitor, and activity tracker)
What this could lead to
If it works, this approach could help people with prediabetes lower their blood sugar and reduce the risk of developing type 2 diabetes.
What could go wrong
This is a small, completed study with 61 participants, so results may not apply to everyone. Lifestyle changes can be hard to maintain long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado- Anschutz Medical Campus
Aurora, Colorado, 80045, United States